KUALA LUMPUR: (Reuters) Malaysian researchers found that treatment with the anti-parasite drug Ivermectin did not prevent patients with Covid-19 from becoming severely ill in a randomised clinical trial published in the Jama Internal Medicine journal on Friday.
The researchers said their findings do not support the use of Ivermectin for patients with Covid-19.
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
